Related Experiment Video

Updated: Mar 16, 2026

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
08:35

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation

Published on: December 29, 2014

17.5K

RetroSternal--Looking Back at Thymectomy for Myasthenia Gravis

Allan H Ropper

    The New England Journal of Medicine
    |August 11, 2016
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
    04:09

    Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

    Published on: September 20, 2024

    1.2K
    Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach
    05:10

    Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach

    Published on: September 15, 2023

    2.1K

    Related Experiment Videos

    Last Updated: Mar 16, 2026

    Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
    08:35

    Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation

    Published on: December 29, 2014

    17.5K
    Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
    04:09

    Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

    Published on: September 20, 2024

    1.2K
    Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach
    05:10

    Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach

    Published on: September 15, 2023

    2.1K

    Related Concept Videos

    Myasthenia Gravis: Overview and Treatment01:20

    Myasthenia Gravis: Overview and Treatment

    3.3K
    Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
    These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
    3.3K
    Myasthenia Gravis: Diagnostic Tests01:15

    Myasthenia Gravis: Diagnostic Tests

    3.0K
    Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
    The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
    3.0K

    Articles linked to this work by shared authors, journal, and citation graph.

    Tactile asymbolia.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2015

    Neuropathies in Systemic Disease.

    Seminars in neurology·2015

    The case for case reports.

    Annals of neurology·2014

    Management of raised intracranial pressure and hyperosmolar therapy.

    Practical neurology·2014

    Evidence-Based Tobacco-Cessation Strategies for Low- and Middle-Income Countries.

    The New England journal of medicine·2026

    Blinatumomab administration in the outpatient setting: Safety and health care utilization.

    Cancer·2026

    Subcutaneous versus intravenous ultra-low dose rituximab in rheumatoid arthritis: a randomised controlled PK-PD non-inferiority trial.

    Rheumatology (Oxford, England)·2026

    The Role of γδ T Cells in Ischemic Stroke: Insights From the Perspective of the Brain-Gut Axis.

    CNS neuroscience & therapeutics·2026

    Macrophage migration inhibitory factor promotes immune evasion in multiple myeloma through myeloid-derived suppressor cell immunosuppression and major histocompatibility complex class I downregulation: implications for targeted therapy.

    Haematologica·2026

    Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications.

    Haematologica·2026

    Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin's lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial.

    Haematologica·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us